Quick answers
- What is Cystagon?
- Cystagon is a brand name of Cysteamine bitartrate, a prescription medicine. The FDA NDC Directory lists 2 Cystagon products in 2 strengths and forms.
- Who makes Cystagon?
- Mylan holds the FDA application for Cystagon (NDA020392, approved August 15, 1994).
- Is there a generic or store brand of Cystagon?
- Other products of Cysteamine bitartrate are listed with the FDA, but none in exactly the same strength and form as a Cystagon product.
- Has Cystagon been recalled?
- No recall linked to Cystagon products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Cystagon is
Each Cystagon product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Cysteamine bitartrate · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| cysteamine bitartrate 150 mg capsule (oral) | Cystagon | None listed | DailyMed |
| cysteamine bitartrate 50 mg capsule (oral) | Cystagon | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Cysteamine bitartrate →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA020392 | Mylan | August 15, 1994 | 2 |
Companies that list Cystagon
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Cystagon products.
- Mylan Pharmaceuticals Inc.2 products
Recalls
No recall linked to Cystagon products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.